Aisling Capital Management LP
Holdings as of 2026-06-30, filed 2026-08-13
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 44 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
14
Value reported by manager
$471.6M
Sum of our stored positions
$471.6M
should match the line above
Disclosure lag
44 d
quarter end to filing
Top 5 concentration
94.4%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
14 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | COM | $341.8M | 4,589,611 | — | 10806X102 |
| MONTE ROSA THERAPEUTICS INC | COM | $37.6M | 1,555,664 | — | 61225M102 |
| SYNDAX PHARMACEUTICALS INC | COM | $28.8M | 1,316,806 | — | 87164F105 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $20.3M | 1,432,336 | — | 20451W101 |
| BICARA THERAPEUTICS INC | COM | $16.9M | 568,919 | — | 055477103 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $7.8M | 1,018,018 | — | 107924102 |
| SCHOLAR ROCK HLDG CORP | COM | $4.2M | 77,031 | — | 80706P103 |
| UROGEN PHARMA LTD | COM | $4M | 108,000 | — | M96088105 |
| BIOMEA FUSION INC | COM | $3M | 2,048,757 | — | 09077A106 |
| ACLARIS THERAPEUTICS INC | COM | $2.3M | 434,455 | — | 00461U105 |
| EUPRAXIA PHARMACEUTICALS INC | COM | $2.1M | 325,000 | — | 29842P105 |
| VTV THERAPEUTICS INC | CL A NEW | $1.9M | 50,000 | — | 918385204 |
| MARKER THERAPEUTICS INC | COM NEW | $478.3K | 325,370 | — | 57055L206 |
| ONKURE THERAPEUTICS INC | COM CL A | $404K | 88,607 | — | 68277Q105 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-13